BRU Equity Snapshot
HYL Weekly Equity Report
Hyloris Pharmaceuticals SA
What the company does
Hyloris Pharmaceuticals SA operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific. The company offers Maxigesic IV for the treatment of post-operative pain; Podofilox gel, a topical antimycotic drug for external genital and perianal warts; Sotalol IV, an intravenous formulation of sotalol for the treatment of atrial fibrillation, and life-threatening ventricular arrhythmias; and Valacyclovir oral suspension for the treatment of herpes virus infections. It also provides Atomoxetine oral liquid for the treatment of attention deficit hyperactivity disorder; XTRAZA and Tranexamic Acid IV RTU for the prevention …
What the weekly tape is saying
HYL closed the latest completed week at 4.75 EUR. The 4-week return is -9.0% and the 12-week return is -15.5%. Trend Signal is inactive, Market Dynamics is -0.81. Setup signature: Risk-first tape with a 17/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 6.12 EUR
- Vs Trend Line
- -22.4%
- Fair Value
- 8.17 EUR
- Vs Fair Value
- -41.9%
- 52W High
- 8.40 EUR
- 52W Low
- 4.51 EUR
- Drawdown
- -43.5%
- Range Position
- 6.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 23
- 52W Active Breadth
- 44.2%
- Sector Scope
- BE Healthcare
- Sector Rank
- 9 of 12
- Sector Percentile
- 27.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
BE Healthcare
- Tracked Peers
- 12
- 4W Rank
- 8 of 12
- Avg 1W
- -3.8%
- Avg 4W
- -1.8%
- Trend Breadth
- 33.3%
- Positive MD
- 41.7%
BE Biotechnology
- Tracked Peers
- 9
- 4W Rank
- 6 of 9
- Avg 1W
- -1.0%
- Avg 4W
- 0.5%
- Trend Breadth
- 22.2%
- Positive RS
- 33.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.81
- 4W MD Change
- 17.4%
- Relative Strength
- -32.03
- 4W RS Change
- -34.9%
- Expectation
- Negative
- Probability
- 41.60%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 15.3K
- 13W Average
- 26.1K
- 52W Average
- 32.0K
- Vs 13W
- 0.6x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 9.2%
- 52W Volatility
- 7.3%
- Upside Weeks
- 21
- Downside Weeks
- 29
- Downside Breadth
- 55.8%
- Avg Gain / Loss
- 6.1% / -4.7%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- BRU
- Country
- BE
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 145.0M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 4.75 EUR | -5.0% | 6.12 EUR | 8.17 EUR | -0.81 | -32.03 | 15.3K | Off |
| 5 Jun 2026 | 5.00 EUR | -0.4% | 6.15 EUR | 8.22 EUR | -0.87 | -26.97 | 24.7K | Off |
| 29 May 2026 | 5.02 EUR | 0.6% | 6.16 EUR | 8.26 EUR | -0.97 | -27.25 | 10.8K | Off |
| 22 May 2026 | 4.99 EUR | -4.4% | 6.19 EUR | 8.30 EUR | -1.00 | -28.23 | 23.0K | Off |
| 15 May 2026 | 5.22 EUR | 1.2% | 6.21 EUR | 8.34 EUR | -0.98 | -23.75 | 13.2K | Off |
| 8 May 2026 | 5.16 EUR | 6.4% | 6.23 EUR | 8.38 EUR | -0.85 | -24.98 | 18.2K | Off |
| 1 May 2026 | 4.85 EUR | -10.8% | 6.26 EUR | 8.43 EUR | -0.89 | -28.43 | 28.3K | Off |
| 24 Apr 2026 | 5.44 EUR | -9.6% | 6.29 EUR | 8.48 EUR | -0.90 | -20.05 | 33.1K | Off |
| 17 Apr 2026 | 6.02 EUR | 25.4% | 6.31 EUR | 8.52 EUR | -0.97 | -15.73 | 59.2K | Off |
| 10 Apr 2026 | 4.80 EUR | -1.0% | 6.31 EUR | 8.57 EUR | -1.11 | -31.90 | 26.5K | Off |
| 3 Apr 2026 | 4.85 EUR | -3.0% | 6.36 EUR | 8.63 EUR | -0.99 | -28.62 | 38.9K | Off |
| 27 Mar 2026 | 5.00 EUR | -11.0% | 6.41 EUR | 8.68 EUR | -0.80 | -23.45 | 34.0K | Off |
| 20 Mar 2026 | 5.62 EUR | -6.3% | 6.46 EUR | 8.73 EUR | -0.46 | -13.19 | 13.6K | Off |
| 13 Mar 2026 | 6.00 EUR | -5.1% | 6.50 EUR | 8.77 EUR | -0.12 | -11.28 | 17.3K | On |